To explore the key targets and signaling pathways of Ansofaxine hydrochloride for inhibiting hepatocellular carcinoma, we first dock SRC, GRB2, PIK3R1, AKT1, and EGFR, which are in the front of the core genes. This evidence concerns the gene GRB2 and hepatocellular carcinoma.